- Home
- ETON vs HNST Comparison
ETON vs HNST Comparison
Compare ETON & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- HNST
- Stock Information
- Founded
- ETON 2017
- HNST 2012
- Country
- ETON United States
- HNST United States
- Employees
- ETON N/A
- HNST N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- HNST Catalog/Specialty Distribution
- Sector
- ETON Health Care
- HNST Consumer Discretionary
- Exchange
- ETON Nasdaq
- HNST Nasdaq
- Market Cap
- ETON 388.3M
- HNST 456.2M
- IPO Year
- ETON 2018
- HNST 2021
- Fundamental
- Price
- ETON $17.68
- HNST $4.00
- Analyst Decision
- ETON Strong Buy
- HNST Buy
- Analyst Count
- ETON 3
- HNST 5
- Target Price
- ETON $29.67
- HNST $6.75
- AVG Volume (30 Days)
- ETON 206.2K
- HNST 3.3M
- Earning Date
- ETON 11-11-2025
- HNST 11-11-2025
- Dividend Yield
- ETON N/A
- HNST N/A
- EPS Growth
- ETON N/A
- HNST N/A
- EPS
- ETON N/A
- HNST 0.06
- Revenue
- ETON $58,181,000.00
- HNST $389,783,000.00
- Revenue This Year
- ETON $105.25
- HNST $6.79
- Revenue Next Year
- ETON $40.84
- HNST $4.70
- P/E Ratio
- ETON N/A
- HNST $65.76
- Revenue Growth
- ETON 85.40
- HNST 9.58
- 52 Week Low
- ETON $5.35
- HNST $3.32
- 52 Week High
- ETON $21.48
- HNST $8.97
- Technical
- Relative Strength Index (RSI)
- ETON 59.16
- HNST 48.12
- Support Level
- ETON $17.24
- HNST $3.79
- Resistance Level
- ETON $18.52
- HNST $4.17
- Average True Range (ATR)
- ETON 0.66
- HNST 0.15
- MACD
- ETON -0.07
- HNST 0.04
- Stochastic Oscillator
- ETON 54.10
- HNST 53.95
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.